Ruth Alon
CIK: 0001796386
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Alon Ruth
Alon Ruth (SEC CIK 0001796386) files insider reports with the SEC as Director of Alpha Tau Medical Ltd. (DRTS) and Director of Silexion Therapeutics Corp (SLXN).
Signal8 holds 3 ownership filings by Alon Ruth (1 Form 3, 2 Form 4), filed between Dec 31, 2025 and Mar 18, 2026. Those filings report 2 transactions, from Feb 9, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Alon Ruth's filings is in RAMAT GAN, L3.
Recent filings by Alon Ruth
Other insiders filing for Alpha Tau Medical Ltd. (DRTS)
- Levy Raphi, Chief Financial Officer
- Avruch Michael, Director
- KIDRON NADAV, Director
- Sofer Uzi, Chief Executive Officer
- Adler Alan, Director
- Blumenfeld S Morry, Director